Mirum Pharmaceuticals, Inc. (MIRM)
96.03
+2.76
(+2.96%)
USD |
NASDAQ |
Jan 22, 16:00
96.55
+0.52
(+0.54%)
After-Hours: 20:00
Mirum Pharmaceuticals Cash from Investing (Quarterly): -2.227M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | -2.43B |
| XOMA Royalty Corp. | 58.21M |
| Arcutis Biotherapeutics, Inc. | -25.25M |
| Recursion Pharmaceuticals, Inc. | -2.549M |
| Insmed, Inc. | -762.23M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 39.68M |
| Cash from Financing (Quarterly) | 16.10M |
| Free Cash Flow | 44.32M |
| Free Cash Flow Per Share (Quarterly) | 0.693 |
| Free Cash Flow to Equity (Quarterly) | 39.63M |
| Free Cash Flow to Firm (Quarterly) | 43.46M |
| Free Cash Flow Yield | 0.91% |